Aniling participates in BBQ2022
Last week, Aniling participated in the BBQ2022 organized by CataloniaBio & HealthTech. After the obliged pause due to the COVID-19 pandemic, the BBQ welcomed nearly 400 professionals looking to meet …
Aniling participates in the virtual DISRUPTOUR program
We are happy to announce that Aniling has been selected to participate in the virtual immersion in the Silicon Valley health and entrepreneurship ecosystem (DISRUPTOUR). This great initiative, organized by …
Aniling is validating GEUS-LB, a molecular diagnostic test for liquid biopsy
Liquid biopsy tests provide access to tumor DNA in a minimally invasive way, offering great potential in oncology applications, including precision medicine, early cancer diagnosis and disease’s follow-up and monitoring. At Aniling, we have developed a new product, GEUS-LB, targeting …